Mitch Higashi, PhD Joins ISPOR as Associate Chief Science Officer

Published Dec 11, 2023

Lawrenceville, NJ, USA—December 11, 2023—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that Mitch Higashi, PhD has joined the Society’s leadership team as Associate Chief Science Officer. In this role Dr Higashi will contribute to the development and deployment of ISPOR’s science and content strategies. He will also collaborate with the Society’s members, groups, stakeholders, and staff to advance initiatives that lead to increased awareness, understanding, and application of HEOR around the world.

Dr Higashi has more than 20 years’ experience in the field of HEOR. Most recently he served as Senior Vice President, HEOR at GeneDx. Previously he was Vice President, HEOR at Bristol-Myers Squibb and has worked in related roles at GE Healthcare and GlaxoSmithKline. Dr Higashi earned his PhD in health economics and outcomes research at the University of Washington. He has been an active member at ISPOR during his career, serving on the Society’s Health Science Policy Council from 2012 – 2017 and most recently as an ISPOR 2023 conference committee co-chair.

“We are thrilled to have Dr Higashi join ISPOR’s staff as our new Associate Chief Science Officer,” stated Chief Science Officer, Laura Pizzi, PharmD, MPH. “Mitch brings significant senior-level leadership experience in HEOR and has a depth of scientific experience and passion that makes him an ideal leader for this role. As the need for HEOR increases worldwide along with its use to inform the challenges of healthcare affordability and access, Mitch’s expertise is pivotal to moving ISPOR’s agenda—and our science—forward.”

Dr Higashi stated, “I am honored to be joining ISPOR at this critical juncture as HEOR moves to the forefront of healthcare decision making globally.”



ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
 | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram  

Related Stories

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.

ISPOR Announces 2024-2025 Board of Directors

May 28, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the results of its recent elections. The Society’s membership selected its new president-elect and 4 new board members. The 2024-2025 board will assume office on July 1.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now